NASDAQ: SPTX
Seaport Therapeutics Inc Stock Ownership - Who owns Seaport Therapeutics?

Insider buying vs selling

Have Seaport Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arch Venture Partners XII LLC10% Owner2026-05-041,100,000$18.00
$19.80MBuy

1 of 1

SPTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SPTX insiders and whales buy or sell their stock.

SPTX Shareholders

What type of owners hold Seaport Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Puretech Health PLC31.17%16,685,013$290.99MInsider
Arch Venture Partners XII LLC11.76%6,294,951$109.78MInsider
General Atlantic Sp LP11.40%6,101,582$106.41MInsider
Gap Coinvestments Cda LP11.40%6,101,582$106.41MInsider
James Healy5.10%2,731,538$47.64MInsider
Daphne Zohar2.23%1,194,001$20.82MInsider
Steven M. Paul1.61%863,031$15.05MInsider
Lana Gladstein0.06%33,515$584.50kInsider
Antony Loebel0.04%20,109$350.70kInsider
Denice Torres0.03%13,406$233.80kInsider

1 of 2

SPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SPTX0.00%74.81%Net BuyingNet Buying
SPRY47.21%52.79%Net SellingNet Selling
CRVS68.16%31.84%Net BuyingNet Buying
DBVT7.15%11.37%Net Selling
XNCR72.60%27.40%Net SellingNet Selling

Seaport Therapeutics Stock Ownership FAQ

Who owns Seaport Therapeutics?

Seaport Therapeutics (NASDAQ: SPTX) is owned by 0.00% institutional shareholders, 74.81% Seaport Therapeutics insiders, and 25.19% retail investors. Puretech Health PLC is the largest individual Seaport Therapeutics shareholder, owning 16.69M shares representing 31.17% of the company. Puretech Health PLC's Seaport Therapeutics shares are currently valued at $299.83M.

If you're new to stock investing, here's how to buy Seaport Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.